Microbot Medical/$MBOT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Microbot Medical
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
- Ticker
- $MBOT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 43
- Headquarters
- Hingham, United States
- Website
- microbotmedical.com
Microbot Medical Metrics
BasicAdvanced
$75M
-
-$0.26
1.05
-
Price and volume
Market cap
$75M
Beta
1.05
52-week high
$2.86
52-week low
$0.93
Average daily volume
904K
Financial strength
Current ratio
18.563
Quick ratio
17.372
Long term debt to equity
0.008
Total debt to equity
0.013
Profitability
EBITDA (TTM)
-18.46
Gross margin (TTM)
-185.26%
Net profit margin (TTM)
-4,722.25%
Operating margin (TTM)
-5,348.84%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-21.72%
Return on equity (TTM)
-32.91%
Valuation
Price to revenue (TTM)
200.433
Price to book
1.08
Price to tangible book (TTM)
1.08
Price to free cash flow (TTM)
-3.868
Free cash flow yield (TTM)
-25.86%
Free cash flow per share (TTM)
-0.287
Growth
Earnings per share change (TTM)
-47.89%
3-year earnings per share growth (CAGR)
-43.48%
10-year earnings per share growth (CAGR)
-12.53%
What the Analysts think about Microbot Medical
Analyst ratings (Buy, Hold, Sell) for Microbot Medical stock.
Analyst projections of the future price of Microbot Medical stock.
Microbot Medical Financial Performance
Revenues and expenses
Microbot Medical Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.